Nanjing Medlander Medical Technology (SH:688273) Shang Hai Zheng Quan Bao·2026-02-02 18:39Core Viewpoint - The announcement details the upcoming listing and circulation of restricted shares for Nanjing Mailland Medical Technology Co., Ltd., which will take place on February 11, 2026, involving a total of 63,173,210 shares, representing 63.1732% of the company's total share capital [2][4][24]. Group 1: Listing Details - The type of stock being listed is restricted shares from the initial public offering (IPO), with a total of 63,173,210 shares set for circulation [2][24]. - The shares will be available for trading starting on February 11, 2026 [4][25]. Group 2: Share Capital Changes - Following the IPO, the company's total share capital was established at 100 million shares, with 77,642,626 shares subject to restrictions and 22,357,374 shares unrestricted [4]. - The total share capital increased to 100.62 million shares after the first grant of restricted stock in May 2023, but was later reduced back to 100 million shares due to the termination of the stock incentive plan in April 2024 [5][6]. Group 3: Shareholder Commitments - Shareholders holding restricted shares have made commitments regarding the lock-up period, including not transferring shares for 36 months post-IPO and adhering to specific conditions for any future share sales [8][10][14]. - If the stock price falls below the IPO price for a specified period, the lock-up period will automatically extend by at least six months [8][10][14]. Group 4: Compliance and Verification - The sponsor institution, Nanjing Securities Co., Ltd., has verified that the shareholders have complied with their commitments regarding the restricted shares, confirming that the listing and circulation of these shares meet legal and regulatory requirements [22][23].